Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yun-Huan Bai, Ya-Fen Jiang & Yun-Sheng Jiang. (2014) Lactobacillus bulgaricus mutants decompose uremic toxins. Renal Failure 36:5, pages 790-794.
Read now
Read now
Zhan-Jun Shu, Ying Cao & UPUR Halmurat. (2011) Gut flora may offer new therapeutic targets for the traditional Chinese medicine enteric dialysis. Expert Opinion on Therapeutic Targets 15:10, pages 1147-1152.
Read now
Read now
Articles from other publishers (92)
Tess E Cooper, Rabia Khalid, Samuel Chan, Jonathan C Craig, Carmel M Hawley, Martin Howell, David W Johnson, Allison Jaure, Armando Teixeira-Pinto & Germaine Wong. (2023) Synbiotics, prebiotics and probiotics for people with chronic kidney disease. Cochrane Database of Systematic Reviews 2023:10.
Crossref
Crossref
Ling-Kang Bu, Pan-Pan Jia, Wei-Guo Li, Yong-Zhi Li, Tian-Yun Li & De-Sheng Pei. (2023) Probiotics mitigate kidney damage after exposure to Sri Lanka's local groundwater from chronic kidney disease with uncertain etiology (CKDu) prevalent area in zebrafish. Aquatic Toxicology 262, pages 106671.
Crossref
Crossref
Ana Zupcic, Paul Slezak & Judith Radloff. (2023) The Gastrointestinal Microbiota as a Potential Cause and Target in Chronic Kidney Disease Accentuating Treatment and Intervention Strategies. Applied Sciences 13:5, pages 3212.
Crossref
Crossref
Zi-Hui Mao, Zhong-Xiuzi Gao, Dong-Wei Liu, Zhang-Suo Liu & Peng Wu. (2023) Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease. Frontiers in Immunology 14.
Crossref
Crossref
Gaetano Emanuele Rizzo, Alessandro Rizzi, Linda Tartaglione, Maria Laura Leo, Luca Viti, Mauro Di Leo & Dario Pitocco. 2023. Gut Microbiota in Aging and Chronic Diseases. Gut Microbiota in Aging and Chronic Diseases
131
151
.
Pradipta Paul, Ridhima Kaul & Ali Chaari. (2022) Renal Health Improvement in Diabetes through Microbiome Modulation of the Gut–Kidney Axis with Biotics: A Systematic and Narrative Review of Randomized Controlled Trials. International Journal of Molecular Sciences 23:23, pages 14838.
Crossref
Crossref
Kuilong Wang, Xiaofen Xu, Qiyuan Shan, Rui Ding, Qiang Lyu, Lichuang Huang, Xinyi Chen, Xin Han, Qiao Yang, Xianan Sang, Mengyun Peng, Min Hao & Gang Cao. (2022)
Integrated gut microbiota and serum metabolomics reveal the protective effect of oleanolic acid on liver and kidney‐injured rats induced by
Euphorbia pekinensis
. Phytotherapy Research.
Crossref
Crossref
Shan Gao, Li-hua Zhao, Xue Tian, Mo-wei Kong, Jian-qiu He, Xiao-chun Ge, Xiao-yan Liu, Zeng-bin Feng & Yu Gao. (2022) Characteristics of Gut Microbiota in Female Patients with Diabetic Microvascular Complications. Journal of Diabetes Research 2022, pages 1-7.
Crossref
Crossref
Behnaz Pourrajab, Nasim Naderi, Leila Janani, Marjan Hajahmadi, Vahid Mofid, Afsaneh Dehnad, Mohammad Hassan Sohouli, Sharieh Hosseini & Farzad Shidfar. (2022)
The impact of probiotic yogurt
versus
ordinary yogurt on serum
sTWEAK
,
sCD163
,
ADMA
,
LCAT
and
BUN
in patients with chronic heart failure: a randomized, triple‐blind, controlled trial
. Journal of the Science of Food and Agriculture 102:13, pages 6024-6035.
Crossref
Crossref
Somkanya Tungsanga, Pisut Katavetin, Wimonrat Panpetch, Kanyarat Udompornpitak, Wilasinee Saisorn, Kearkiat Praditpornsilpa, Somchai Eiam-Ong, Kriang Tungsanga, Somying Tumwasorn & Asada Leelahavanichkul. (2022)
Lactobacillus rhamnosus
L34 attenuates chronic kidney disease progression in a 5/6 nephrectomy mouse model through the excretion of anti-inflammatory molecules
. Nephrology Dialysis Transplantation 37:8, pages 1429-1442.
Crossref
Crossref
Sandra Wagner, Thomas Merkling, Marie Metzger, Laetitia Koppe, Maurice Laville, Marie-Christine Boutron-Ruault, Luc Frimat, Christian Combe, Ziad A. Massy, Bénédicte Stengel & Denis Fouque. (2022) Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort. Frontiers in Nutrition 9.
Crossref
Crossref
Yinghui Huang, Wang Xin, Jiachuan Xiong, Mengying Yao, Bo Zhang & Jinghong Zhao. (2022) The Intestinal Microbiota and Metabolites in the Gut-Kidney-Heart Axis of Chronic Kidney Disease. Frontiers in Pharmacology 13.
Crossref
Crossref
Seyed Mojtaba Ghoreishy, Nooshin Shirzad, Manouchehr Nakhjavani, Alireza Esteghamati, Kurosh Djafarian & Ahmad Esmaillzadeh. (2022) Effect of daily consumption of probiotic yoghurt on albumin to creatinine ratio, eGFR and metabolic parameters in patients with type 2 diabetes with microalbuminuria: study protocol for a randomised controlled clinical trial. BMJ Open 12:3, pages e056110.
Crossref
Crossref
Sneha Sarwar, Md. Jamal Hossain, Nafis Md. Irfan, Tamima Ahsan, Md. Saidul Arefin, Arebia Rahman, Abdullah Alsubaie, Badr Alharthi, Mayeen Uddin Khandaker, David A. Bradley, Talha Bin Emran & Sheikh Nazrul Islam. (2022) Renoprotection of Selected Antioxidant-Rich Foods (Water Spinach and Red Grape) and Probiotics in Gentamicin-Induced Nephrotoxicity and Oxidative Stress in Rats. Life 12:1, pages 60.
Crossref
Crossref
Jing Liu, JianYong Zhong, HaiChun Yang, DongQin Wang, Ying Zhang, YuMeng Yang, GuoLan Xing & Valentina Kon. (2022) Biotic Supplements in Patients With Chronic Kidney Disease: Meta-Analysis of Randomized Controlled Trials. Journal of Renal Nutrition 32:1, pages 10-21.
Crossref
Crossref
Camelia Oana Iatcu, Aimee Steen & Mihai Covasa. (2021) Gut Microbiota and Complications of Type-2 Diabetes. Nutrients 14:1, pages 166.
Crossref
Crossref
Zhe Feng, Ting Wang, Sheng Dong, Hongli Jiang, Jianzhong Zhang, Hafiz Khuram Raza & Genping Lei. (2021) Association between gut dysbiosis and chronic kidney disease: a narrative review of the literature. Journal of International Medical Research 49:10, pages 030006052110532.
Crossref
Crossref
Han Zhu, Chujin Cao, Zhongcai Wu, Heping Zhang, Zhihong Sun, Meng Wang, Huzi Xu, Zhi Zhao, Yuxi Wang, Guangchang Pei, Qian Yang, Fengming Zhu, Juan Yang, Xuan Deng, Yu Hong, Yinzheng Li, Jie Sun, Fan Zhu, Mengxia Shi, Kun Qian, Ting Ye, Xuezhi Zuo, Fenfei Zhao, Jing Guo, Gang Xu, Ying Yao & Rui Zeng. (2021) The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease. Cell Metabolism 33:10, pages 1926-1942.e8.
Crossref
Crossref
Amgad Zaky, Sarah J. Glastras, May Y. W. Wong, Carol A. Pollock & Sonia Saad. (2021) The Role of the Gut Microbiome in Diabetes and Obesity-Related Kidney Disease. International Journal of Molecular Sciences 22:17, pages 9641.
Crossref
Crossref
Yueming Li, Minhui Dai, Jianqin Yan, Fang Liu, Xi Wang, Lizhen Lin, Mei Huang, Cuifang Li, Rui Wen, Jiao Qin & Hui Xu. (2021) Colonic dialysis can influence gut flora to protect renal function in patients with pre-dialysis chronic kidney disease. Scientific Reports 11:1.
Crossref
Crossref
Fengping Liu, Xuefang Xu, Lin Chao, Ke Chen, Amo Shao, Danqin Sun, Yan Hong, Renjing Hu, Peng Jiang, Nan Zhang, Yonghong Xiao, Feng Yan & Ninghan Feng. (2021) Alteration of the Gut Microbiome in Chronic Kidney Disease Patients and Its Association With Serum Free Immunoglobulin Light Chains. Frontiers in Immunology 12.
Crossref
Crossref
Peng Wang, Jianbo Yang, Yupeng Zhang, Li Zhang, Xuejin Gao & Xinying Wang. (2021) Risk Factors for Renal Impairment in Adult Patients With Short Bowel Syndrome. Frontiers in Nutrition 7.
Crossref
Crossref
Chih-Yu Yang, Ting-Wen Chen, Wan-Lun Lu, Shih-Shin Liang, Hsien-Da Huang, Ching-Ping Tseng & Der-Cherng Tarng. (2021) Synbiotics Alleviate the Gut Indole Load and Dysbiosis in Chronic Kidney Disease. Cells 10:1, pages 114.
Crossref
Crossref
Hai Ning Wee, Jian-Jun Liu, Jianhong Ching, Jean-Paul Kovalik & Su Chi Lim. (2021) The Kynurenine Pathway in Acute Kidney Injury and Chronic Kidney Disease. American Journal of Nephrology 52:10-11, pages 771-787.
Crossref
Crossref
So Mi Kim & Il han Song. (2020) The clinical impact of gut microbiota in chronic kidney disease. The Korean Journal of Internal Medicine 35:6, pages 1305-1316.
Crossref
Crossref
Song Hee Lee, Hee Sang You, Hee-Gyoo Kang, Sang Sun Kang & Sung Hee Hyun. (2020) Association between Altered Blood Parameters and Gut Microbiota after Synbiotic Intake in Healthy, Elderly Korean Women. Nutrients 12:10, pages 3112.
Crossref
Crossref
Mohsen Mazidi, Niloofar Shekoohi, Adrian Covic, Dimitri P. Mikhailidis & Maciej Banach. (2020) Adverse Impact of Desulfovibrio spp. and Beneficial Role of Anaerostipes spp. on Renal Function: Insights from a Mendelian Randomization Analysis. Nutrients 12:8, pages 2216.
Crossref
Crossref
Cristina T. Roth-Stefanski, Carla Dolenga, Lia S. Nakao, Roberto Pecoits-Filho, Thyago P. de Moraes & Andrea N. Moreno-Amaral. (2020) Pilot Study of Probiotic Supplementation on Uremic Toxicity and Inflammatory Cytokines in Chronic Kidney Patients. Current Nutrition & Food Science 16:4, pages 470-480.
Crossref
Crossref
Anila Duni, Evangelia Dounousi, Paraskevi Pavlakou, Theodoros Eleftheriadis & Vassilios Liakopoulos. (2020) Hypertension in Chronic Kidney Disease: Novel Insights. Current Hypertension Reviews 16:1, pages 45-54.
Crossref
Crossref
Fabio Sallustio, Claudia Curci, Vincenzo Di Leo, Anna Gallone, Francesco Pesce & Loreto Gesualdo. (2019) A New Vision of IgA Nephropathy: The Missing Link. International Journal of Molecular Sciences 21:1, pages 189.
Crossref
Crossref
Khara Lucius. (2019) Diet, Botanical Medicine, and Nutraceuticals for Chronic Kidney Disease. Alternative and Complementary Therapies 25:6, pages 312-319.
Crossref
Crossref
Sibei Tao, Siying Tao, Yiming Cheng, Jing Liu, Liang Ma & Ping Fu. (2019) Effects of probiotic supplements on the progression of chronic kidney disease: A meta‐analysis. Nephrology 24:11, pages 1122-1130.
Crossref
Crossref
Stefanos Roumeliotis, Athanasios Roumeliotis, Evangelia Dounousi, Theodoros Eleftheriadis & Vassilios Liakopoulos. (2019) Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review. Nutrients 11:8, pages 1911.
Crossref
Crossref
Luis Vitetta, Hannah Llewellyn & Debbie Oldfield. (2019) Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia. Microorganisms 7:8, pages 228.
Crossref
Crossref
Antonio Sircana, Franco De Michieli, Renato Parente, Luciana Framarin, Nicola Leone, Mara Berrutti, Elena Paschetta, Daria Bongiovanni & Giovanni Musso. (2019) Gut microbiota, hypertension and chronic kidney disease: Recent advances. Pharmacological Research 144, pages 390-408.
Crossref
Crossref
Catherine McFarlane, Christiane I. Ramos, David W. Johnson & Katrina L. Campbell. (2019) Prebiotic, Probiotic, and Synbiotic Supplementation in Chronic Kidney Disease: A Systematic Review and Meta-analysis. Journal of Renal Nutrition 29:3, pages 209-220.
Crossref
Crossref
Matthew Snelson, Nicole J Kellow & Melinda T Coughlan. (2019) Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights. Advances in Nutrition 10:2, pages 303-320.
Crossref
Crossref
Nima Jazani, Javad Savoj, Michael Lustgarten, Wei Lau & Nosratola Vaziri. (2019) Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease. Diseases 7:1, pages 21.
Crossref
Crossref
B. G. Lukichev, A. Sh. Rumyantsev, I. Yu. Panina & V. Akimenko. (2019) COLONIC MICROBIOTA AND CHRONIC KIDNEY DISEASES INTESTINAL MICROBIOTA AND CHRONIC KIDNEY DISEASE. PART II. Nephrology (Saint-Petersburg) 23:1, pages 18-31.
Crossref
Crossref
Charat Thongprayoon, Wisit Kaewput, Spencer T. Hatch, Tarun Bathini, Konika Sharma, Karn Wijarnpreecha, Patompong Ungprasert, Matthew D’Costa, Michael A. Mao & Wisit Cheungpasitporn. (2018) Effects of Probiotics on Inflammation and Uremic Toxins Among Patients on Dialysis: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 64:2, pages 469-479.
Crossref
Crossref
PriyaHaridas Anupama, Narayan Prasad, VictorineB Nzana, JP Tiwari, Milly Mathew & Georgi Abraham. (2019) Dietary management in slowing down the progression of CKDu. Indian Journal of Nephrology 0:0, pages 0.
Crossref
Crossref
Jing Gong, Sanjeev Noel, Jennifer L. Pluznick, Abdel Rahim A. Hamad & Hamid Rabb. (2019) Gut Microbiota-Kidney Cross-Talk in Acute Kidney Injury. Seminars in Nephrology 39:1, pages 107-116.
Crossref
Crossref
Yanhuan Feng, Lingzhi Li, Fan Guo, Yanping Li, Yan Liang, Lin Bai, Liang Ma & Ping Fu. (2018) Protective effects of SKLB023 on a mouse model of unilateral ureteral obstruction by the modulation of gut microbiota. RSC Advances 8:70, pages 40232-40242.
Crossref
Crossref
Markku Lehto & Per-Henrik Groop. (2018) The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders. Frontiers in Endocrinology 9.
Crossref
Crossref
Tao Yang, Elaine M. Richards, Carl J. Pepine & Mohan K. Raizada. (2018) The gut microbiota and the brain–gut–kidney axis in hypertension and chronic kidney disease. Nature Reviews Nephrology 14:7, pages 442-456.
Crossref
Crossref
Somayyeh Firouzi & Fahimeh Haghighatdoost. (2018) The effects of prebiotic, probiotic, and synbiotic supplementation on blood parameters of renal function: A systematic review and meta-analysis of clinical trials. Nutrition 51-52, pages 104-113.
Crossref
Crossref
Amanda de Faria Barros, Natália A. Borges, Lia Sumie Nakao, Carla J. Dolenga, Flavia Lima do Carmo, Dennis de Carvalho Ferreira, Peter Stenvinkel, Peter Bergman, Bengt Lindholm & Denise Mafra. (2018) Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial. Journal of Functional Foods 46, pages 378-383.
Crossref
Crossref
C. Antza, S. Stabouli & V. Kotsis. (2018) Gut microbiota in kidney disease and hypertension. Pharmacological Research 130, pages 198-203.
Crossref
Crossref
Liliana Simões-Silva, Ricardo Araujo, Manuel Pestana, Isabel Soares-Silva & Benedita Sampaio-Maia. (2018) The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis. Pharmacological Research 130, pages 143-151.
Crossref
Crossref
Alireza Mafi, Gholamreza Namazi, Alireza Soleimani, Fereshteh Bahmani, Esmat Aghadavod & Zatollah Asemi. (2018) Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Food & Function 9:9, pages 4763-4770.
Crossref
Crossref
Natalia O. Litbarg. 2018. Integrative Medicine. Integrative Medicine
411
421.e11
.
Zarin sadat Ebrahimi, Ensieh Nasli-Esfahani, Azadeh Nadjarzade & Hassan Mozaffari-khosravi. (2017) Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: a randomized, double-blind, clinical trial. Journal of Diabetes & Metabolic Disorders 16:1.
Crossref
Crossref
Nearmeen M. Rashad, Amal S. El-Shal, Abdelaziz I. Amin & Manar H. Soliman. (2017) Effects of probiotics supplementation on macrophage migration inhibitory factor and clinical laboratory feature of polycystic ovary syndrome. Journal of Functional Foods 36, pages 317-324.
Crossref
Crossref
Tawfik Khoury, Keren Tzukert, Roy Abel, Ayman Abu Rmeileh, Ronen Levi & Yaron Ilan. (2017) The gut-kidney axis in chronic renal failure: A new potential target for therapy. Hemodialysis International 21:3, pages 323-334.
Crossref
Crossref
Mohammadreza Ardalan & Sepideh Zununi Vahed. (2017) Gut microbiota and renal transplant outcome. Biomedicine & Pharmacotherapy 90, pages 229-236.
Crossref
Crossref
Allyson Zabell & W. H. Wilson Tang. (2017) Targeting the Microbiome in Heart Failure. Current Treatment Options in Cardiovascular Medicine 19:4.
Crossref
Crossref
R. G. Armani, A. Ramezani, A. Yasir, S. Sharama, M. E. F. Canziani & D. S. Raj. (2017) Gut Microbiome in Chronic Kidney Disease. Current Hypertension Reports 19:4.
Crossref
Crossref
Alice Sabatino, Giuseppe Regolisti, Carmela Cosola, Loreto Gesualdo & Enrico Fiaccadori. (2017) Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Current Diabetes Reports 17:3.
Crossref
Crossref
David Briskey, Patrick Tucker, David W. Johnson & Jeff S. Coombes. (2016) The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clinical and Experimental Nephrology 21:1, pages 7-15.
Crossref
Crossref
Mohsen Mazidi, Peyman Rezaie, Gordon Ferns & Hassan Vatanparast. (2017) Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials. Nutrients 9:1, pages 20.
Crossref
Crossref
Secundino Cigarran Guldris, Emilio González Parra & Aleix Cases Amenós. (2017) Gut microbiota in chronic kidney disease. Nefrología (English Edition) 37:1, pages 9-19.
Crossref
Crossref
Secundino Cigarran Guldris, Emilio González Parra & Aleix Cases Amenós. (2017) Microbiota intestinal en la enfermedad renal crónica. Nefrología 37:1, pages 9-19.
Crossref
Crossref
Keerati Wanchai, Anchalee Pongchaidecha, Varanuj Chatsudthipong, Siriporn C. Chattipakorn, Nipon Chattipakorn & Anusorn Lungkaphin. (2017) Role of Gastrointestinal Microbiota on Kidney Injury and the Obese Condition. The American Journal of the Medical Sciences 353:1, pages 59-69.
Crossref
Crossref
Mari C. Fuentes, Teresa Lajo, Juan M. Carrión & Jordi Cuñé. (2016) A randomized clinical trial evaluating a proprietary mixture of Lactobacillus plantarum strains for lowering cholesterol1. Mediterranean Journal of Nutrition and Metabolism 9:2, pages 125-135.
Crossref
Crossref
B. Sampaio-Maia, L. Simões-Silva, M. Pestana, R. Araujo & I.J. Soares-Silva. 2016.
65
94
.
Girish N. Nadkarni & Joseph A. Vassalotti. 2016. Lifestyle Medicine. Lifestyle Medicine
311
320
.
Erin M Schwenger, Aaron M Tejani & Peter S Loewen. (2015) Probiotics for preventing urinary tract infections in adults and children. Cochrane Database of Systematic Reviews 2015:12.
Crossref
Crossref
Rabi Yacoub, Deepak Kaji, Shanti N. Patel, Priya K. Simoes, Deepthi Busayavalasa, Girish N. Nadkarni, John C. He, Steven G. Coca & Jaime Uribarri. (2016) Association between probiotic and yogurt consumption and kidney disease: insights from NHANES. Nutrition Journal 15:1.
Crossref
Crossref
Laetitia Koppe, Denise Mafra & Denis Fouque. (2015) Probiotics and chronic kidney disease. Kidney International 88:5, pages 958-966.
Crossref
Crossref
Megan Rossi, David W. Johnson & Katrina L. Campbell. (2015) The Kidney–Gut Axis: Implications for Nutrition Care. Journal of Renal Nutrition 25:5, pages 399-403.
Crossref
Crossref
Clara Barrios, Michelle Beaumont, Tess Pallister, Judith Villar, Julia K. Goodrich, Andrew Clark, Julio Pascual, Ruth E. Ley, Tim D. Spector, Jordana T. Bell & Cristina Menni. (2015) Gut-Microbiota-Metabolite Axis in Early Renal Function Decline. PLOS ONE 10:8, pages e0134311.
Crossref
Crossref
A. Sabatino, G. Regolisti, I. Brusasco, A. Cabassi, S. Morabito & E. Fiaccadori. (2014) Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrology Dialysis Transplantation 30:6, pages 924-933.
Crossref
Crossref
M. Van den Nieuwboer, R.J. Brummer, F. Guarner, L. Morelli, M. Cabana & E. Claassen. (2015) The administration of probiotics and synbiotics in immune compromised adults: is it safe?. Beneficial Microbes 6:1, pages 3-17.
Crossref
Crossref
Megan Rossi, David W Johnson, Mark Morrison, Elaine Pascoe, Jeff S Coombes, Josephine M Forbes, Brett C McWhinney, Jacobus PJ Ungerer, Goce Dimeski & Katrina L Campbell. (2014) SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrology 15:1.
Crossref
Crossref
Luis Vitetta, Rachel Manuel, Joyce Zhou, Anthony Linnane, Sean Hall & Samantha Coulson. (2014) The Overarching Influence of the Gut Microbiome on End-Organ Function: The Role of Live Probiotic Cultures. Pharmaceuticals 7:9, pages 954-989.
Crossref
Crossref
B. Guida, R. Germanò, R. Trio, D. Russo, B. Memoli, L. Grumetto, F. Barbato & M. Cataldi. (2014) Effect of short-term synbiotic treatment on plasma p-cresol levels in patients with chronic renal failure: A randomized clinical trial. Nutrition, Metabolism and Cardiovascular Diseases 24:9, pages 1043-1049.
Crossref
Crossref
Maria De Angelis, Eustacchio Montemurno, Maria Piccolo, Lucia Vannini, Gabriella Lauriero, Valentina Maranzano, Giorgia Gozzi, Diana Serrazanetti, Giuseppe Dalfino, Marco Gobbetti & Loreto Gesualdo. (2014) Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN). PLoS ONE 9:6, pages e99006.
Crossref
Crossref
Ali Ramezani & Dominic S. Raj. (2014) The Gut Microbiome, Kidney Disease, and Targeted Interventions. Journal of the American Society of Nephrology 25:4, pages 657-670.
Crossref
Crossref
Arpita Patra, Arpita Mandal, Suchismita Roy, Shreya Mandal, Keshab Chandra Mondal & Dilip Kumar Nandi. (2014) Protective effect of selected urease positive Lactobacillus strains on acetaminophen induced uremia in rats. Biomedicine & Preventive Nutrition 4:2, pages 271-276.
Crossref
Crossref
Sookrang Jo, Minhee Kang, Kyoim Lee, Changmin Lee, Seunggon Kim, Sungjae Park, Taewoo Kim & Heemyung Park. (2014) Probiotic dietary supplementation in a dog with chronic kidney disease. Journal of Biomedical Research 15:1, pages 40-43.
Crossref
Crossref
Ranganathan Natarajan, Bohdan Pechenyak, Usha Vyas, Pari Ranganathan, Alan Weinberg, Peter Liang, Mary C. Mallappallil, Allen J. Norin, Eli A. Friedman & Subodh J. Saggi. (2014) Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients. BioMed Research International 2014, pages 1-9.
Crossref
Crossref
Alessandro Di Cerbo, Federica Pezzuto, Lucia Palmieri, Valentina Rottigni, Tommaso Iannitti & Beniamino Palmieri. (2013) Clinical and experimental use of probiotic formulations for management of end-stage renal disease: an update. International Urology and Nephrology 45:6, pages 1569-1576.
Crossref
Crossref
Luis Vitetta, Anthony Linnane & Glenda Gobe. (2013) From the Gastrointestinal Tract (GIT) to the Kidneys: Live Bacterial Cultures (Probiotics) Mediating Reductions of Uremic Toxin Levels via Free Radical Signaling. Toxins 5:11, pages 2042-2057.
Crossref
Crossref
Maria Cagetti, Stefano Mastroberardino, Egle Milia, Fabio Cocco, Peter Lingström & Guglielmo Campus. (2013) The Use of Probiotic Strains in Caries Prevention: A Systematic Review. Nutrients 5:7, pages 2530-2550.
Crossref
Crossref
Luis Vitetta & Glenda Gobe. (2013) Uremia and chronic kidney disease: The role of the gut microflora and therapies with pro- and prebiotics. Molecular Nutrition & Food Research 57:5, pages 824-832.
Crossref
Crossref
Nosratola D. Vaziri, Jakk Wong, Madeleine Pahl, Yvette M. Piceno, Jun Yuan, Todd Z. DeSantis, Zhenmin Ni, Tien-Hung Nguyen & Gary L. Andersen. (2013) Chronic kidney disease alters intestinal microbial flora. Kidney International 83:2, pages 308-315.
Crossref
Crossref
Hye Sun HyunKyung Hoon PaikHee Yeon Cho. (2013)
p
-Cresyl sulfate and indoxyl sulfate in pediatric patients on chronic dialysis
. Korean Journal of Pediatrics 56:4, pages 159.
Crossref
Crossref
Zatollah Asemi, Zohreh Zare, Hossein Shakeri, Sima-sadat Sabihi & Ahmad Esmaillzadeh. (2013) Effect of Multispecies Probiotic Supplements on Metabolic Profiles, hs-CRP, and Oxidative Stress in Patients with Type 2 Diabetes. Annals of Nutrition and Metabolism 63:1-2, pages 1-9.
Crossref
Crossref
Usha Vyas & Natarajan Ranganathan. (2012) Probiotics, Prebiotics, and Synbiotics: Gut and Beyond. Gastroenterology Research and Practice 2012, pages 1-16.
Crossref
Crossref
Stephanie McCain, Matthew C Allender, Juergen Schumacher & Edward Ramsay. (2011) The Effects of a Probiotic on Blood Urea Nitrogen and Creatinine Concentrations in Large Felids. Journal of Zoo and Wildlife Medicine 42:3, pages 426-429.
Crossref
Crossref
Mark Rishniw & Susan G. Wynn. (2011) Azodyl, a synbiotic, fails to alter azotemia in cats with chronic kidney disease when sprinkled onto food. Journal of Feline Medicine and Surgery 13:6, pages 405-409.
Crossref
Crossref
Natarajan Ranganathan, Pari Ranganathan, Eli A. Friedman, Anthony Joseph, Barbara Delano, David S. Goldfarb, Paul Tam, A. Venketeshwer Rao, Emmanuel Anteyi & Carlos Guido Musso. (2010) Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease. Advances in Therapy 27:9, pages 634-647.
Crossref
Crossref